Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03293706
NCT03293706
Completed
Not Applicable

Evaluation of Carbohydrates (CHO): Tolerance, Breath Hydrogen and Methane

Abbott Nutrition1 site in 1 country13 target enrollmentSeptember 21, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGastro-Intestinal Tolerance

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastro-Intestinal Tolerance
Sponsor
Abbott Nutrition
Enrollment
13
Locations
1
Primary Endpoint
Breath hydrogen
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The study is single-blind with a randomized, cross-over design to evaluate gastrointestinal tolerance of carbohydrate blends.

Registry
clinicaltrials.gov
Start Date
September 21, 2017
End Date
November 15, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Males or non-pregnant females in good health.
  • •Eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.

Exclusion Criteria

  • •Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes, cardio-vascular disease or GI disease.
  • •Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.

Outcomes

Primary Outcomes

Breath hydrogen

Time Frame: 0 to 7 hours

Assessed in exhaled gasses

Secondary Outcomes

  • GI tolerance symptoms(0 to 48 hours)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Study to Evaluate the Tolerability of Prebiotics on the MicrobiotaHealthy
NCT02628652Kaleido Biosciences45
Recruiting
Not Applicable
Acceptability and Tolerance Study of a Plant-based Tube FeedNutrition Disorders
NCT06209593Société des Produits Nestlé (SPN)15
Completed
Not Applicable
Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary FiberSigns and Symptoms, Digestive
NCT02530762Cargill45
Completed
Not Applicable
Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary FiberSigns and Symptoms, Digestive
NCT02532985Cargill45
Completed
Phase 3
Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)Osteoarthritis
NCT00092703Organon and Co6,000